Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;33(1):195-204.
doi: 10.1007/s00198-021-06081-4. Epub 2021 Aug 19.

Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort

Affiliations

Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort

C Vendrami et al. Osteoporos Int. 2022 Jan.

Abstract

Thyroid-stimulating hormone (TSH) excess or deficiency influences bone density and fracture risk. Nevertheless, does TSH in the reference range influence bone health? In euthyroid postmenopausal women, TSH levels in the reference range were positively associated with trabecular bone score and negatively with incident fractures, without affecting BMD.

Purpose: Subclinical hyperthyroidism is associated with low bone mineral density (BMD) and increased fracture risk. In healthy postmenopausal women, association between thyroid-stimulating hormone (TSH) in the normal range and BMD is contradictory. Trabecular bone score (TBS), an index of bone micro-architecture, is often decreased in secondary osteoporosis (OP). The aim was to determine the association between thyroid hormones (TSH, fT4) and BMD, TBS, and the incident 5-year OP fractures, in euthyroid post-menopausal women.

Methods: We assessed 1475 women of the CoLaus/OsteoLaus cohort. We evaluated BMD at lumbar spine, femoral neck and total hip, lumbar spine TBS, and vertebral fracture with DXA. Incident major OP fractures were evaluated 5 years later by questionnaire and DXA. Women with anti-osteoporotic, antidiabetic, thyroid-modifying, hormone replacement, or systemic corticoid treatment were excluded.

Results: Five hundred thirty-three women (age 68.4 ± 7.3 years, BMI 25.9 ± 4.6 kg/m2, TSH 2.03 ± 0.87 mU/l, fT4 15.51 ± 1.85 pmol/l) met the inclusion criteria. There was no significant association between TSH or fT4 and BMD measures at any site. A positive association was found between TSH and TBS (β = 0.138, p < 0.01), even after adjusting for age, BMI, and duration of menopause (β = 0.086, p < 0.05). After a 5-year follow-up, women with incident major OP fractures had lower TSH levels (1.77 ± 0.13 vs. 2.05 ± 0.04 mU/l, p < 0.05) than women without fractures, while no difference was found for fT4.

Conclusion: In euthyroid postmenopausal women, TSH levels were positively associated with TBS and negatively with incident fractures, without affecting BMD. Further studies are needed to evaluate the influence of thyroid hormones on TBS.

Keywords: Bone mineral density; Fractures; Osteoporosis; Thyroid hormones; Trabecular bone score.

PubMed Disclaimer

Conflict of interest statement

Colin Vendrami, Pedro Marques-Vidal, Elena Gonzalez Rodriguez, Gérard Waeber, and Olivier Lamy declare that they have no conflict of interest related to this manuscript. Didier Hans is a co-owner of the TBS patent and holds stock options and royalties in the Medimaps group.

Figures

Fig. 1
Fig. 1
Flowchart with exclusion criteria
Fig. 2
Fig. 2
Association between fT4 and TSH and lumbar spine (LS) BMD T-score, femoral neck BMD T-score, and TBS with regression line

Similar articles

Cited by

References

    1. Compston JE, McClung MR, Leslie WD. Osteoporosis. The Lancet. 2019;393(10169):364–376. doi: 10.1016/S0140-6736(18)32112-3. - DOI - PubMed
    1. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002;17(12):2222–2230. doi: 10.1359/jbmr.2002.17.12.2222. - DOI - PubMed
    1. Svedbom A, Ivergård M, Hernlund E, Rizzoli R, Kanis JA. Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos. 2014;9(1):187. doi: 10.1007/s11657-014-0187-y. - DOI - PubMed
    1. Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19(4):399–428. doi: 10.1007/s00198-008-0560-z. - DOI - PMC - PubMed
    1. University of Sheffield, UK © Centre for Metabolic Bone Diseases. Calculation Tool. FRAX ®Fracture Risk Assessment Tool. https://www.sheffield.ac.uk/FRAX/tool.aspx?lang=en